Inhibition of lipopolysaccharide/ATP-induced release of interleukin-18 by KN-62 and glyburide

European Journal of Pharmacology

Volumn 482, Issue 1-3, 2003, Pages 325-328

  Mühl, Heiko ^a   Höfler, Sonja ^a   Pfeilschifter, Josef ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Glyburide; Inflammation; Interleukin 18; Lipopolysaccharide; Monocyte; Purinoreceptor subtype P2x7

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; ABC TRANSPORTER; ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; INTERLEUKIN 18; LIPOPOLYSACCHARIDE; PURINE P2X7 RECEPTOR;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG POTENCY; HUMAN; HUMAN CELL; INHIBITION KINETICS; ION TRANSPORT; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0345599926     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.09.062     Document Type: Article

References (33)

1. Buell G., Chessell I.P., Michel A.D., Collo G., Salazzo M., Herren S., Gretener D., Grahames C., Kaur R., Kosco-Vilbois M.H., Humphrey P.P. Blockade of human P2X7 receptor function with a monoclonal antibody. Blood. 92:1998;3521-3528.
2. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood. 87:1996;2095-2147.
3. Dinarello C.A. Targeting interleukin 18 with interleukin 18 binding protein. Ann. Rheum. Dis. 59(Suppl 1):2000;17-20.
4. Di Virgilio F., Chiozzi P., Falzoni S., Ferrari D., Sanz J.M., Venketaraman V., Baricordi O.R. Cytolytic P2X purinoceptors. Cell Death Differ. 5:1998;191-199.
5. Eschke D., Wust M., Hauschildt S., Nieber K. Pharmacological characterization of the P2X(7) receptor on human macrophages using the patch-clamp technique. Naunyn-Schmiedeberg's Arch. Pharmacol. 365:2002;168-171.
6. Gracie J.A., Robertson S.E., McInnes I.B. Interleukin-18. J. Leukoc. Biol. 73:2003;213-224.
7. Grahames C.B., Michel A.D., Chessell I.P., Humphrey P.P. Pharmacological characterization of ATP- and LPS-induced IL-1β release in human monocytes. Br. J. Pharmacol. 127:1999;915-921.
8. Grobmyer S.R., Lin E., Lowry S.F., Rivadeneira D.E., Potter S., Barie P.S., Nathan C.F. Elevation of IL-18 in human sepsis. J. Clin. Immunol. 20:2000;212-215.
9. Hamon Y., Luciani M.F., Becq F., Verrier B., Rubartelli A., Chimini G. Interleukin-1β secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. Blood. 90:1997;2911-2915.
10. Humphreys B.D., Dubyak G.R. Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-γ in the human THP-1 monocytic cell line. J. Immunol. 157:1996;5627-5637.
11. Humphreys B.D., Virginio C., Surprenant A., Rice J., Dubyak G.R. Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Mol. Pharmacol. 54:1998;22-32.
12. Im S.H., Barchan D., Maiti P.K., Raveh L., Souroujon M.C., Fuchs S. Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18. FASEB J. 15:2001;2140-2148.
13. Jander S., Stoll G. Increased serum levels of the interferon-γ- inducing cytokine interleukin-18 in myasthenia gravis. Neurology. 59:2002;287-289.
14. Labasi J.M., Petrushova N., Donovan C., McCurdy S., Lira P., Payette M.M., Brissette W., Wicks J.R., Audoly L., Gabel C.A. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 168:2002;6436-6445.
15. Mehta V.B., Hart J., Wewers M.D. ATP-stimulated release of interleukin (IL)-1β and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J. Biol. Chem. 276:2001;3820-3826.
16. Netea M.G., Fantuzzi G., Kullberg B.J., Stuyt R.J., Pulido E.J., McIntyre R.C. Jr., Joosten L.A., Van der Meer J.W., Dinarello C.A. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J. Immunol. 164:2000;2644-2649.
17. Nicoletti F., Conget I., Di Marco R., Speciale A.M., Morinigo R., Bendtzen K., Gomis R. Serum levels of the interferon-γ-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes. Diabetologia. 44:2001;309-311.
18. Nicoletti F., Di Marco R., Mangano K., Patti F., Reggio E., Nicoletti A., Bendtzen K., Reggio A. Increased serum levels of interleukin-18 in patients with multiple sclerosis. Neurology. 57:2001;342-344.
19. Nicoletti F., Di Marco R., Papaccio G., Conget I., Gomis R., Bernardini R., Sims J.E., Shoenfeld Y., Bendtzen K. Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct. Eur. J. Immunol. 33:2003;2278-2286.
20. Nold M., Hauser I.A., Höfler S., Goede A., Eberhardt W., Ditting T., Geiger H., Pfeilschifter J., Mühl H. IL-18BPa:Fc cooperates with immunosuppressive drugs in human whole blood. Biochem. Pharmacol. 66:2003;501-506.
21. Perregaux D., Gabel C.A. Inerleukin-1 beta maturation and release in response to ATP and Nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 269:1994;15195-15203.
22. Perregaux D.G., McNiff P., Laliberte R., Conklyn M., Gabel C.A. ATP acts as an agonist to promote stimulus-induced secretion of IL-1β and IL-18 in human blood. J. Immunol. 165:2000;4615-4623.
23. Pizarro T.T., Michie M.H., Bentz M., Woraratanadharm J., Smith M.F. Jr., Foley E., Moskaluk C.A., Bickston S.J., Cominelli F. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J. Immunol. 162:1999;6829-6835.
24. Plater-Zyberk C., Joosten L.A., Helsen M.M., Sattonnet-Roche P., Siegfried C., Alouani S., van De Loo F.A., Graber P., Aloni S., Cirillo R., Lubberts E., Dinarello C.A., van Den Berg W.B., Chvatchko Y. Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J. Clin. Invest. 108:2001;1825-1832.
25. Puren A.J., Fantuzzi G., Gu Y., Su M.S., Dinarello C.A. Interleukin-18 (IFNγ-inducing factor) induces IL-8 and IL-1β via TNFα production from non-CD14+ human blood mononuclear cells. J. Clin. Invest. 101:1998;711-721.
26. Puren A.J., Fantuzzi G., Dinarello C.A. Gene expression, synthesis, and secretion of interleukin-18 and interleukin-1β are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc. Natl. Acad. Sci. U. S. A. 96:1999;2256-2261.
27. Siegmund B., Fantuzzi G., Rieder F., Gamboni-Robertson F., Lehr H.A., Hartmann G., Dinarello C.A., Endres S., Eigler A. Neutralization of interleukin-18 reduces severity in murine coliti and intestinal IFNγ and TNFα production. Am. J. Physiol. 281:2001;R1264-R1273.
28. Solle M., Labasi J., Perregaux D.G., Stam E., Petrushova N., Koller B.H., Griffiths R.J., Gabel C.A. Altered cytokine production in mice lacking P2X(7) receptors. J. Biol. Chem. 276:2001;125-132.
29. Stuyt R.J., Netea M.G., Kim S.H., Novick D., Rubinstein M., Kullberg B.J., Van der Meer J.W., Dinarello C.A. Differential roles of interleukin-18 (IL-18) and IL12 for induction of γ-interferon by staphylococcal cell wall components and superantigens. Infect. Immun. 69:2001;5025-5030.
30. Ten Hove T., Corbaz A., Amitai H., Aloni S., Belzer I., Graber P., Drillenburg P., van Deventer S.J., Chvatchko Y., Te Velde A.A. Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNFα production in mice. Gastroenterology. 121:2001;1372-1379.
31. Wildbaum G., Youssef S., Grabie N., Karin N. Neutralizing antibodies to IFN-γ-inducing factor prevent experimental autoimmune encephalomyelitis. J Immunol. 161:1998;6368-6374.
32. Williams C.L., Phelps S.H., Porter R.A. Expression of Ca2+/calmodulin-dependent protein kinase types II and IV, and reduced DNA synthesis due to the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl piperazine) in small cell lung carcinoma. Biochem. Pharmacol. 51:1996;707-715.
33. Yamamura M., Kawashima M., Taniai M., Yamauchi H., Tanimoto T., Kurimoto M., Morita Y., Ohmoto Y., Makino H. Interferon-γ-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum. 44:2001;275-285.